Catalyzing Innovation, Enabling Impact
A holding company founded in 2019, dedicated to exceptional entrepreneurs, aims to convert trailblazing science into breakthrough therapies for cancer, fibrosis, inflammation, autoimmune and infectious diseases. With offices in Houston, New York, and Boston, the company has access to the vibrant biotech ecosystem of these communities.
The deep experience of our team is a resource for founders to build exceptional biotech companies. The company aggressively seeks to leverage non-dilutive funding mechanisms to preserve founder and investor equity.